Stocktoria
Alpha Cognition Inc. ACOG
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-06-09
Chart by TradingView
2/9
Piotroski F — financial health
3.69
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Financials | |||
| Revenue | $10.2M | — | — |
| Operating income | -$22.7M | -$12.0M | -$9.9M |
| Net income | -$20.7M | -$14.8M | -$13.8M |
| Operating cash flow | -$20.4M | -$7.8M | -$8.8M |
| Free cash flow | -$20.7M | -$7.8M | — |
| Total assets | $79.7M | $50.7M | $2.5M |
| Total liabilities | $17.2M | $11.6M | $7.2M |
| Shareholders' equity | $62.5M | $39.1M | -$4.7M |
| Ratios | |||
| Operating margin | -221.7% | — | — |
| Net margin | -202.2% | — | — |
| FCF margin | -202.3% | — | — |
| Return on assets | -25.9% | -29.1% | -561.3% |
| Return on equity | -33.1% | -37.8% | 292.6% |
| Current ratio | 8.65 | 15.00 | 0.73 |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 3.69 (safe)
- Working capital / assets 0.876
- Retained earnings / assets -1.218
- EBIT / assets -0.284
- Equity / liabilities 3.635
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001655923 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.